+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Conjugate Vaccine Market Research Report by Type, by End User, by Pathogen Type, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5122299
  • Report
  • July 2021
  • Region: United States
  • 85 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Conjugate Vaccine Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Conjugate Vaccine Market.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Conjugate Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Conjugate Vaccine Market was examined across Monovalent and Multivalent.
  • Based on Indication, the Conjugate Vaccine Market was examined across Diphtheria and Pertussis, Influenza, Meningococcal, and Pneumococcal.
  • Based on End User, the Conjugate Vaccine Market was examined across Adults Conjugate Vaccine and Pediatrics Conjugate Vaccine.
  • Based on Pathogen Type, the Conjugate Vaccine Market was examined across Bacterial Conjugate Vaccine, Combination Conjugate Vaccine, and Viral Conjugate Vaccine.
  • Based on Geography, the Conjugate Vaccine Market was examined across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Conjugate Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Conjugate Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Conjugate Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Conjugate Vaccine Market?
4. What is the competitive strategic window for opportunities in the United States Conjugate Vaccine Market?
5. What are the technology trends and regulatory frameworks in the United States Conjugate Vaccine Market?
6. What is the market share of the leading vendors in the United States Conjugate Vaccine Market?
7. What modes and strategic moves are considered suitable for entering the United States Conjugate Vaccine Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Indication Outlook
3.5. End User Outlook
3.6. Pathogen Type Outlook
3.7. Geography Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Conjugate Vaccine Market, by Type
6.1. Introduction
6.2. Monovalent
6.3. Multivalent

7. Conjugate Vaccine Market, by Indication
7.1. Introduction
7.2. Diphtheria and Pertussis
7.3. Influenza
7.4. Meningococcal
7.5. Pneumococcal

8. Conjugate Vaccine Market, by End User
8.1. Introduction
8.2. Adults Conjugate Vaccine
8.3. Pediatrics Conjugate Vaccine

9. Conjugate Vaccine Market, by Pathogen Type
9.1. Introduction
9.2. Bacterial Conjugate Vaccine
9.3. Combination Conjugate Vaccine
9.4. Viral Conjugate Vaccine

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis, By Key Player
10.4. Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion

11. Company Usability Profiles

12. Appendix
12.1. Discussion Guide
12.2. License & Pricing

List of Figures
Figure 1. United States Conjugate Vaccine Market Size, 2020 Vs 2026 (USD Million)
Figure 2. United States Conjugate Vaccine Market Size, by Type, 2020 (USD Million)
Figure 3. United States Conjugate Vaccine Market Size, by Indication, 2020 (USD Million)
Figure 4. United States Conjugate Vaccine Market Size, by End-user, 2020 (USD Million)
Figure 5. United States Conjugate Vaccine Market Size, by Pathogen Type, 2020 (USD Million)
Figure 6. United States Conjugate Vaccine Market Size, by Geography, 2020 Vs 2026 (USD Million)
Figure 7. United States Conjugate Vaccine Market Size, 2018-2026 (USD Million)
Figure 8. United States Conjugate Vaccine Market: Market Dynamics
Figure 9. United States Conjugate Vaccine Market Size, by Type, 2020 Vs 2026 (%)
Figure 10. United States Conjugate Vaccine Market Size, by Type, 2020 Vs 2026 (USD Million)
Figure 11. Competitive Strategic Window for United States Conjugate Vaccine Market Size, by Type, 2026
Figure 12. United States Conjugate Vaccine Market Size, by Monovalent, 2018-2026 (USD Million)
Figure 13. United States Conjugate Vaccine Market Size, by Monovalent, by Geography, 2020 Vs 2026 (USD Million)
Figure 14. United States Conjugate Vaccine Market Size, by Multivalent, 2018-2026 (USD Million)
Figure 15. United States Conjugate Vaccine Market Size, by Multivalent, by Geography, 2020 Vs 2026 (USD Million)
Figure 16. United States Conjugate Vaccine Market Size, by Indication, 2020 Vs 2026 (%)
Figure 17. United States Conjugate Vaccine Market Size, by Indication, 2020 Vs 2026 (USD Million)
Figure 18. Competitive Strategic Window for United States Conjugate Vaccine Market Size, by Indication, 2026
Figure 19. United States Conjugate Vaccine Market Size, by Diphtheria and Pertussis, 2018-2026 (USD Million)
Figure 20. United States Conjugate Vaccine Market Size, by Diphtheria and Pertussis, by Geography, 2020 Vs 2026 (USD Million)
Figure 21. United States Conjugate Vaccine Market Size, by Influenza, 2018-2026 (USD Million)
Figure 22. United States Conjugate Vaccine Market Size, by Influenza, by Geography, 2020 Vs 2026 (USD Million)
Figure 23. United States Conjugate Vaccine Market Size, by Meningococcal, 2018-2026 (USD Million)
Figure 24. United States Conjugate Vaccine Market Size, by Meningococcal, by Geography, 2020 Vs 2026 (USD Million)
Figure 25. United States Conjugate Vaccine Market Size, by Pneumococcal, 2018-2026 (USD Million)
Figure 26. United States Conjugate Vaccine Market Size, by Pneumococcal, by Geography, 2020 Vs 2026 (USD Million)
Figure 27. United States Conjugate Vaccine Market Size, by End-user, 2020 Vs 2026 (%)
Figure 28. United States Conjugate Vaccine Market Size, by End-user, 2020 Vs 2026 (USD Million)
Figure 29. Competitive Strategic Window for United States Conjugate Vaccine Market Size, by End-user, 2026
Figure 30. United States Conjugate Vaccine Market Size, by Adults Conjugate Vaccine, 2018-2026 (USD Million)
Figure 31. United States Conjugate Vaccine Market Size, by Adults Conjugate Vaccine, by Geography, 2020 Vs 2026 (USD Million)
Figure 32. United States Conjugate Vaccine Market Size, by Pediatrics Conjugate Vaccine, 2018-2026 (USD Million)
Figure 33. United States Conjugate Vaccine Market Size, by Pediatrics Conjugate Vaccine, by Geography, 2020 Vs 2026 (USD Million)
Figure 34. United States Conjugate Vaccine Market Size, by Pathogen Type, 2020 Vs 2026 (%)
Figure 35. United States Conjugate Vaccine Market Size, by Pathogen Type, 2020 Vs 2026 (USD Million)
Figure 36. Competitive Strategic Window for United States Conjugate Vaccine Market Size, by Pathogen Type, 2026
Figure 37. United States Conjugate Vaccine Market Size, by Bacterial Conjugate Vaccine, 2018-2026 (USD Million)
Figure 38. United States Conjugate Vaccine Market Size, by Bacterial Conjugate Vaccine, by Geography, 2020 Vs 2026 (USD Million)
Figure 39. United States Conjugate Vaccine Market Size, by Combination Conjugate Vaccine, 2018-2026 (USD Million)
Figure 40. United States Conjugate Vaccine Market Size, by Combination Conjugate Vaccine, by Geography, 2020 Vs 2026 (USD Million)
Figure 41. United States Conjugate Vaccine Market Size, by Viral Conjugate Vaccine, 2018-2026 (USD Million)
Figure 42. United States Conjugate Vaccine Market Size, by Viral Conjugate Vaccine, by Geography, 2020 Vs 2026 (USD Million)
Figure 43. United States Conjugate Vaccine Market: Fpnv Positioning Matrix
Figure 44. United States Conjugate Vaccine Market: Share, by Key Player, 2020
Figure 45. Competitive Scenario Analysis in United States Conjugate Vaccine Market, by Type

List of Tables
Table 1. United States Conjugate Vaccine Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. United States Conjugate Vaccine Market Size, 2018-2026 (USD Million)
Table 4. United States Conjugate Vaccine Market Size, by Type, 2018-2026 (USD Million)
Table 5. United States Conjugate Vaccine Market Size, by Monovalent, by Geography, 2018-2026 (USD Million)
Table 6. United States Conjugate Vaccine Market Size, by Multivalent, by Geography, 2018-2026 (USD Million)
Table 7. United States Conjugate Vaccine Market Size, by Indication, 2018-2026 (USD Million)
Table 8. United States Conjugate Vaccine Market Size, by Diphtheria and Pertussis, by Geography, 2018-2026 (USD Million)
Table 9. United States Conjugate Vaccine Market Size, by Influenza, by Geography, 2018-2026 (USD Million)
Table 10. United States Conjugate Vaccine Market Size, by Meningococcal, by Geography, 2018-2026 (USD Million)
Table 11. United States Conjugate Vaccine Market Size, by Pneumococcal, by Geography, 2018-2026 (USD Million)
Table 12. United States Conjugate Vaccine Market Size, by End-user, 2018-2026 (USD Million)
Table 13. United States Conjugate Vaccine Market Size, by Adults Conjugate Vaccine, by Geography, 2018-2026 (USD Million)
Table 14. United States Conjugate Vaccine Market Size, by Pediatrics Conjugate Vaccine, by Geography, 2018-2026 (USD Million)
Table 15. United States Conjugate Vaccine Market Size, by Pathogen Type, 2018-2026 (USD Million)
Table 16. United States Conjugate Vaccine Market Size, by Bacterial Conjugate Vaccine, by Geography, 2018-2026 (USD Million)
Table 17. United States Conjugate Vaccine Market Size, by Combination Conjugate Vaccine, by Geography, 2018-2026 (USD Million)
Table 18. United States Conjugate Vaccine Market Size, by Viral Conjugate Vaccine, by Geography, 2018-2026 (USD Million)
Table 19. United States Conjugate Vaccine Market: Scores
Table 20. United States Conjugate Vaccine Market: Business Strategy
Table 21. United States Conjugate Vaccine Market: Product Satisfaction
Table 22. United States Conjugate Vaccine Market: Ranking
Table 23. United States Conjugate Vaccine Market: Share, by Key Player, 2020
Table 24. United States Conjugate Vaccine Market: Merger & Acquisition
Table 25. United States Conjugate Vaccine Market: Agreement, Collaboration, & Partnership
Table 26. United States Conjugate Vaccine Market: New Product Launch & Enhancement
Table 27. United States Conjugate Vaccine Market: Investment & Funding
Table 28. United States Conjugate Vaccine Market: Award, Recognition, & Expansion
Table 29. United States Conjugate Vaccine Market: License & Pricing
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll